@article {Rozaliyani140, author = {Anna Rozaliyani and Rudyanto Sedono and Anwar Jusuf and Cleopas M. Rumende and Wahju Aniwidyaningsih and Erlina Burhan and Prasenohadi and Diah Handayani and Evy Yunihastuti and Forman E. Siagian and Achmad M. Jayusman and Adria Rusli and Saleha Sungkar and Joedo Prihartono and Ferry Hagen and Jacques F. Meis and Retno Wahyuningsih}, title = {A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit}, volume = {40}, number = {2}, pages = {140--146}, year = {2019}, doi = {10.15537/smj.2019.2.22940}, publisher = {Saudi Medical Journal}, abstract = {Objectives: To improve the quality of invasive pulmonary aspergillosis (IPA) management for intensive care unit (ICU) patients using a practical diagnostic scoring model.Methods: This nested case-control study aimed to determine the incidence of IPA in 405 ICU patients, between July 2012 and June 2014, at 6 hospitals in Jakarta, Indonesia. Phenotypic identifications and galactomannan (GM) tests of sera and lung excreta were performed in mycology laboratory, Parasitology Department, Faculty of Medicine, Universitas Indonesia in Jakarta, Indonesia.Results: The incidence of IPA in the ICUs was 7.7\% (31 of 405 patients). A scoring model used for IPA diagnosis showed 4 variables as the most potential risk factors: lung excreta GM index (score 2), solid organ malignancy (score 2), pulmonary tuberculosis (score 2), and systemic corticosteroids (score 1). Patients were included in a high-risk group if their score was \>2, and in a low-risk group if their score was \<2.Conclusion: This study provides a novel diagnosis scoring model to predict IPA in ICU patients. Using this model, a more rapid diagnosis and treatment of IPA may be possible. The application of the diagnosis scoring should be preceded by specified pre-requisites.}, issn = {0379-5284}, URL = {https://smj.org.sa/content/40/2/140}, eprint = {https://smj.org.sa/content/40/2/140.full.pdf}, journal = {Saudi Medical Journal} }